Calcimedica Inc stock is traded at $1.36, with a volume of 15,209. It is up +4.62% in the last 24 hours and down -8.72% over the past month. CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
Previous Close:
$1.30
Open:
$1.28
24h Volume:
15,209
Relative Volume:
0.16
Market Cap:
$9.29M
Revenue:
-
Net Income/Loss:
-$19.54M
P/E Ratio:
-
EPS:
-$1.31
Net Cash Flow:
-$21.18M
1W Performance:
-6.85%
1M Performance:
-8.72%
6M Performance:
-56.30%
1Y Performance:
-91.11%
1-Day Range:
$1.27$1.36
1-Week Range:
$1.16$1.75
52-Week Range:
$1.00$36.00
Calcimedica Inc Stock (CALC) Company Profile
Name
Calcimedica IncSector
HealthcareIndustry
BiotechnologyPhone
858-952-5500Address
505 COAST BOULEVARD SOUTH, LA JOLLA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS